Literature DB >> 26350318

Metabolism and Pathogenicity of Pseudomonas aeruginosa Infections in the Lungs of Individuals with Cystic Fibrosis.

Gregory C Palmer, Marvin Whiteley.   

Abstract

Individuals with the genetic disease cystic fibrosis (CF) accumulate mucus or sputum in their lungs. This sputum is a potent growth substrate for a range of potential pathogens, and the opportunistic bacterium Pseudomonas aeruginosa is generally most difficult of these to eradicate. As a result, P. aeruginosa infections are frequently maintained in the CF lung throughout life, and are the leading cause of death for these individuals. While great effort has been expended to better understand and treat these devastating infections, only recently have researchers begun to rigorously examine the roles played by specific nutrients in CF sputum to cue P. aeruginosa pathogenicity. This chapter summarizes the current state of knowledge regarding how P. aeruginosa metabolism in CF sputum affects initiation and maintenance of these infections. It contains an overview of CF lung disease and the mechanisms of P. aeruginosa pathogenicity. Several model systems used to study these infections are described with emphasis on the challenge of replicating the chronic infections observed in humans with CF. Nutrients present in CF sputum are surveyed, and the impacts of these nutrients on the infection are discussed. The chapter concludes by addressing the future of this line of research including the use of next-generation technologies and the potential for metabolism-based therapeutics.

Entities:  

Mesh:

Year:  2015        PMID: 26350318     DOI: 10.1128/microbiolspec.MBP-0003-2014

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  16 in total

Review 1.  Virulence attenuating combination therapy: a potential multi-target synergy approach to treat Pseudomonas aeruginosa infections in cystic fibrosis patients.

Authors:  Elana Shaw; William M Wuest
Journal:  RSC Med Chem       Date:  2020-02-19

2.  Influence of Excipients on the Antimicrobial Activity of Tobramycin Against Pseudomonas aeruginosa Biofilms.

Authors:  Tania Bahamondez-Canas; Hugh D C Smyth
Journal:  Pharm Res       Date:  2018-01-02       Impact factor: 4.200

3.  Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis.

Authors:  Catherine R Armbruster; Tom Coenye; Lhousseine Touqui; Jennifer M Bomberger
Journal:  J Cyst Fibros       Date:  2019-11-02       Impact factor: 5.482

4.  Glutaminyl-tRNA Synthetase from Pseudomonas aeruginosa: Characterization, structure, and development as a screening platform.

Authors:  Yaritza Escamilla; Casey A Hughes; Jan Abendroth; David M Dranow; Samantha Balboa; Frank B Dean; James M Bullard
Journal:  Protein Sci       Date:  2019-12-24       Impact factor: 6.725

5.  Bacteriophage-Loaded Poly(lactic-co-glycolic acid) Microparticles Mitigate Staphylococcus aureus Infection and Cocultures of Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Pranav P Kalelkar; Dina A Moustafa; Milan Riddick; Joanna B Goldberg; Nael A McCarty; Andrés J García
Journal:  Adv Healthc Mater       Date:  2022-01-07       Impact factor: 11.092

6.  Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.

Authors:  Perrine Bortolotti; Benjamin Hennart; Camille Thieffry; Guillaume Jausions; Emmanuel Faure; Teddy Grandjean; Marion Thepaut; Rodrigue Dessein; Delphine Allorge; Benoit P Guery; Karine Faure; Eric Kipnis; Bertrand Toussaint; Audrey Le Gouellec
Journal:  BMC Microbiol       Date:  2016-07-08       Impact factor: 3.605

7.  Bile signalling promotes chronic respiratory infections and antibiotic tolerance.

Authors:  F Jerry Reen; Stephanie Flynn; David F Woods; Niall Dunphy; Muireann Ní Chróinín; David Mullane; Stephen Stick; Claire Adams; Fergal O'Gara
Journal:  Sci Rep       Date:  2016-07-19       Impact factor: 4.379

8.  Detection of Pseudomonas aeruginosa Metabolite Pyocyanin in Water and Saliva by Employing the SERS Technique.

Authors:  Olga Žukovskaja; Izabella Jolan Jahn; Karina Weber; Dana Cialla-May; Jürgen Popp
Journal:  Sensors (Basel)       Date:  2017-07-25       Impact factor: 3.576

9.  Bronchial Epithelial Cells from Cystic Fibrosis Patients Express a Specific Long Non-coding RNA Signature upon Pseudomonas aeruginosa Infection.

Authors:  Viviane Balloy; Remya Koshy; Lea Perra; Harriet Corvol; Michel Chignard; Loïc Guillot; Vinod Scaria
Journal:  Front Cell Infect Microbiol       Date:  2017-05-29       Impact factor: 5.293

10.  Identification of a Novel Polyamine Scaffold With Potent Efflux Pump Inhibition Activity Toward Multi-Drug Resistant Bacterial Pathogens.

Authors:  Renee M Fleeman; Ginamarie Debevec; Kirsten Antonen; Jessie L Adams; Radleigh G Santos; Gregory S Welmaker; Richard A Houghten; Marc A Giulianotti; Lindsey N Shaw
Journal:  Front Microbiol       Date:  2018-06-14       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.